ZA895710B - The use of imexon as immune suppressive and pharmaceutical compositions containing imexon - Google Patents

The use of imexon as immune suppressive and pharmaceutical compositions containing imexon

Info

Publication number
ZA895710B
ZA895710B ZA895710A ZA895710A ZA895710B ZA 895710 B ZA895710 B ZA 895710B ZA 895710 A ZA895710 A ZA 895710A ZA 895710 A ZA895710 A ZA 895710A ZA 895710 B ZA895710 B ZA 895710B
Authority
ZA
South Africa
Prior art keywords
imexon
pharmaceutical compositions
compositions containing
immune suppressive
cell
Prior art date
Application number
ZA895710A
Other languages
English (en)
Inventor
Dieter Dr Herrmann
Herrmann Dr Dieter
Rainer Dr Haag
Haag Dr Rainer
Elmar Dr Gosies
Gosies Dr Elmar
Uwe Prof Bicker
Bicker Prof Uwe
Wolfgang Dr Kampe
Kampe Dr Wolfgang
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA895710B publication Critical patent/ZA895710B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
ZA895710A 1988-07-28 1989-07-27 The use of imexon as immune suppressive and pharmaceutical compositions containing imexon ZA895710B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3825667A DE3825667A1 (de) 1988-07-28 1988-07-28 Verwendung von imexon als immunsuppressivum

Publications (1)

Publication Number Publication Date
ZA895710B true ZA895710B (en) 1990-04-25

Family

ID=6359767

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895710A ZA895710B (en) 1988-07-28 1989-07-27 The use of imexon as immune suppressive and pharmaceutical compositions containing imexon

Country Status (14)

Country Link
EP (1) EP0352652B1 (fr)
JP (1) JP2848634B2 (fr)
KR (1) KR0135757B1 (fr)
AT (1) ATE117551T1 (fr)
AU (1) AU619027B2 (fr)
CA (1) CA1333771C (fr)
DE (2) DE3825667A1 (fr)
DK (1) DK175199B1 (fr)
HU (1) HU206827B (fr)
IE (1) IE66680B1 (fr)
IL (1) IL91138A (fr)
PH (1) PH26684A (fr)
PT (1) PT91293B (fr)
ZA (1) ZA895710B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005055952A2 (fr) * 2003-12-08 2005-06-23 The Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions anticancereuses synergiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2528460A1 (de) * 1975-06-26 1977-01-13 Boehringer Mannheim Gmbh Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE2530398A1 (de) * 1975-07-08 1977-01-27 Boehringer Mannheim Gmbh Organische verbindung
DE2736296A1 (de) * 1977-08-12 1979-02-22 Boehringer Mannheim Gmbh Verwendung von 2-cyan-aziridin und seinen derivaten zur immunstimulierung

Also Published As

Publication number Publication date
PT91293A (pt) 1990-02-08
IE66680B1 (en) 1996-01-24
HUT52378A (en) 1990-07-28
PT91293B (pt) 1995-03-01
DE3825667A1 (de) 1990-03-15
DK175199B1 (da) 2004-07-05
HU206827B (en) 1993-01-28
IE892448L (en) 1990-01-28
JP2848634B2 (ja) 1999-01-20
DE3825667C2 (fr) 1991-06-27
KR0135757B1 (ko) 1998-04-23
CA1333771C (fr) 1995-01-03
PH26684A (en) 1992-09-15
IL91138A0 (en) 1990-03-19
ATE117551T1 (de) 1995-02-15
AU619027B2 (en) 1992-01-16
EP0352652A3 (fr) 1991-09-04
IL91138A (en) 1994-10-21
AU3887789A (en) 1990-02-01
KR900001369A (ko) 1990-02-27
DE58908926D1 (de) 1995-03-09
EP0352652A2 (fr) 1990-01-31
EP0352652B1 (fr) 1995-01-25
DK363389A (da) 1990-01-29
DK363389D0 (da) 1989-07-21
JPH0288521A (ja) 1990-03-28

Similar Documents

Publication Publication Date Title
EP0252290A3 (en) Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
HU9500192D0 (en) Bis-n-substituted staurosporin derivatives and pharmaceutical composition containing them and other active components
AU4113889A (en) Diorganopolysiloxane polymers containing a benzalmalonate functional group
EP0573423A4 (en) Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof
AU4323693A (en) Enniatines and enniatine derivates used to control endoparasites
EP0261224A4 (fr) Peptides synthetiques utiles pour combattre l'htlv-iii, compositions et utilisations desdits peptides.
HUT63063A (en) Process for producing antibodies against cd44 cell surface glycoprotein and immunosuppressant pharmaceutical compositions comprising same
IL104261A (en) Azacyclic and azabicyclic compounds, their preparation and pharmaceutical compositions comprising them
PT84258A (en) Process for the preparation of cross-protective human monoclonal antibodies and of pharmaceutical compositions containing the same
FR2694296B1 (fr) Peptides inhibant l'activité des protéines ras, préparation et utilisation.
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
CA2094275A1 (fr) Methodes et compositions pour le traitement de maladies cytoproliferatives
ZA895710B (en) The use of imexon as immune suppressive and pharmaceutical compositions containing imexon
HU903011D0 (en) Process for the preparation of cyclopeptides and pharmaceutical compositions containing them
UA27055C2 (uk) Лікарський препарат імуhозаміhhої дії hа осhові клітиhhої суспеhзії та спосіб лікуваhhя сиhдрому hабутого імуhодефіциту (віл-іhфекції) з використаhhям цього препарату
FR2706303B1 (fr) Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
NO893279L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-amino-4-morfolino-6-propyl-1,3,5-triaziner.
GB2004183A (en) Compositions containing caffeine and ephedrine or their derivatives
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
MY106961A (en) Antiviral tetrahydroimidazo[1,4] benzodiazepines
IL94402A0 (en) Pharmaceutical compositions containing imidazodiazepines for the treatment of neurological symptoms
EP0285883A3 (fr) Bactoboline comme médicament prophylactique ou thérapeutique pour des maladies auto-immunes, et comme médicament immunosuppressif
MY104813A (en) Pharmaceutical compositions of tebufelone